Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04400 |
| Species: | Homo sapiens |
| Position : | chr17:47950000-47955000 |
| Year: | 2024 |
| Title: | CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | neuroblastoma |
| PMID: | 38636893 |
| MONDO: | MONDO:0005072 |
| Tissue: | adrenal gland |
| Tissue Ontology ID: | UBERON:0002369 |
| Cell Source: | SK-N-BE(2) |
| CVCL ID: | CVCL_0528 |
| Cell Type: | neuroblastoma cell |
| Experiment Type: | Enhancer activity assay, TF binding assay, Chromatin interaction assay |
| High Throughput Method: | ChIP-seq; Hi-C; CUT&Tag; RNA-seq; microarray |
| Low Throughput Method: | Luciferase Reporter Assay, 3C-RT-qPCR; CUT&RUN-RT-qPCR; RT-RT-qPCR; Western blot |
| Target gene : | CDK5RAP3 |
| TF name : | MEIS2 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04399 | chr17:47950000-47955000 | adrenal gland | neuroblastoma cell | neuroblastoma |